Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.3.1 (
alkaline phosphatase
)
47,916
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Bone morphogenetic protein (BMP) signaling regulates body axis determination, apoptosis, and differentiation of various types of cells including neuron, gut, and bone cells. However, the molecules involved in such BMP regulation of biological events have not been fully understood. Here, we examined the involvement of
Cas-interacting zinc finger protein
(
CIZ
) in the modulation of BMP2-induced osteoblastic cell differentiation.
CIZ
overexpression in osteoblastic MC3T3E1 cells suppressed BMP2-enhanced expression of
alkaline phosphatase
, osteocalcin, and type I collagen genes. Upstream analyses revealed that
CIZ
overexpression also suppressed BMP2-induced enhancement of the mRNA expression of Cbfa1, which is a critical transcription factor for osteoblastic differentiation. BMP-induced Smad1 and Smad5 activation of GCCG-mediated transcription was blocked in the presence of
CIZ
overexpression.
CIZ
overexpression alone in the absence of BMP2 moderately enhanced basal levels of Cbfa1 mRNA expression.
CIZ
overexpression also enhanced 1.8-kb Cbfa1 promoter activity in the absence of BMP2, whereas it suppressed the promoter activity in the presence of BMP2. Finally,
CIZ
overexpression suppressed the formation of mineralized nodules in osteoblastic cell cultures. These data indicate that
CIZ
is a novel type inhibitor of BMP/Smad signaling.
...
PMID:Negative regulation of bone morphogenetic protein/Smad signaling by Cas-interacting zinc finger protein in osteoblasts. 1202 67
Osteoporosis is a major health problem; however, the mechanisms regulating adult bone mass are poorly understood.
Cas-interacting zinc finger protein
(
CIZ
) is a nucleocytoplasmic shuttling protein that localizes at cell adhesion plaques that form where osteoblasts attach to substrate. To investigate the potential role of
CIZ
in regulating adult bone mass, we examined the bones in
CIZ
-deficient mice. Bone volume was increased and the rates of bone formation were increased in
CIZ
-deficient mice, whereas bone resorption was not altered.
CIZ
deficiency enhanced the levels of mRNA expression of genes encoding proteins related to osteoblastic phenotypes, such as
alkaline phosphatase
(
ALP
) as well as osterix mRNA expression in whole long bones. Bone marrow cells obtained from the femora of
CIZ
-deficient mice revealed higher
ALP
activity in culture and formed more mineralized nodules than wild-type cells.
CIZ
deficiency enhanced bone morphogenetic protein (BMP)-induced osteoblastic differentiation in bone marrow cells in cultures, indicating that BMP is the target of
CIZ
action.
CIZ
deficiency increased newly formed bone mass after femoral bone marrow ablation in vivo. Finally, BMP-2-induced bone formation on adult mouse calvariae in vivo was enhanced by
CIZ
deficiency. These results establish that
CIZ
suppresses the levels of adult bone mass through inhibition of BMP-induced activation of osteoblasts.
...
PMID:The nucleocytoplasmic shuttling protein CIZ reduces adult bone mass by inhibiting bone morphogenetic protein-induced bone formation. 1578 86